11/20/2024
7:30 AM | Hoth Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
3:15 PM | Hoth Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
7:00 AM | Hoth Therapeutics (Issuer)
Knie Robb (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:15 PM | Hoth Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
5:10 AM | Hoth Therapeutics (Filer)
| Form DEFA14A | |
06/18/2024
5:15 AM | Hoth Therapeutics (Filer)
| Form ARS | |
06/18/2024
5:07 AM | Hoth Therapeutics (Filer)
| Form DEF 14A | |
06/17/2024
3:41 PM | Hoth Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:00 PM | Hoth Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/22/2024
3:15 PM | Hoth Therapeutics (Filer)
| Form 424B3 | |
04/21/2024
11:15 PM | Hoth Therapeutics (Filer)
| Form EFFECT | |
04/11/2024
3:15 PM | Hoth Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2024
3:07 PM | Hoth Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
6:15 AM | Hoth Therapeutics (Filer)
| Form 424B3 | |
03/28/2024
6:00 AM | Hoth Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:47 PM | ARMISTICE CAPITAL, LLC (Filed by)
Hoth Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024
2:03 PM | Hoth Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
4:00 PM | Hoth Therapeutics (Issuer)
Knie Robb (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:01 PM | Hoth Therapeutics (Issuer)
Linsley Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:01 PM | Hoth Therapeutics (Issuer)
Pavell Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:01 PM | Hoth Therapeutics (Issuer)
Sarnoff David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:01 PM | Hoth Therapeutics (Issuer)
Springer Graig (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
